News & Views
Regenerative Medicines Funding Supports BIGT Goals
Mar 23 2010
The BioIndustry Association (BIA) has welcomed Lord Mandelson’s announcement that the Engineering and Physical Sciences Research Council (EPSRC) will invest £5.3 million over the next five years in a Centre for
Innovative Manufacturing in Regenerative Medicine at Loughborough University. The centre will also receive £3 million from 28 industrial and government partners. The Bioscience Innovation and Growth Team Review and Refresh of Bioscience 2015, published in January 2009, called for investment in the emerging regenerative medicine industry, which offers the possibility of cures, rather than life-long treatments. The Government’s New Industry New Jobs proposals and the Office for Life Sciences’ Life Sciences Blueprint also recognised that high technology manufacturing, such as that required in the regenerative medicines field, will be crucial to the UK’s economic future. Clive Dix, BIA Chairman, said: “This announcement about investment in regenerative medicine further exhibits the Government’s commitment to ensuring that the cutting edge science coming from the UK’s
innovative life sciences sector is turned into the world-leading treatments of the future.”
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark